PA HB1123 | 2023-2024 | Regular Session
Status
Spectrum: Partisan Bill (Republican 8-0)
Status: Introduced on May 5 2023 - 25% progression
Action: 2023-05-05 - Referred to HEALTH
Pending: House Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 5 2023 - 25% progression
Action: 2023-05-05 - Referred to HEALTH
Pending: House Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.
Title
Providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.
Sponsors
Rep. Dawn Keefer [R] | Rep. Joe Hamm [R] | Rep. Robert Kauffman [R] | Rep. Joseph D'Orsie [R] |
Rep. David Rowe [R] | Rep. David Zimmerman [R] | Rep. Barbara Gleim [R] | Rep. Robert Leadbeter [R] |
History
Date | Chamber | Action |
---|---|---|
2023-05-05 | House | Referred to HEALTH |